This interaction helps cells move quickly, reshape their internal framework, and repair damaged tissues
After four weeks, if well-tolerated by the patient, the dose can be increased gradually (5 mg, then 7.5 mg, up to a maximum of 15 mg per week)
These genetic insights do not predict your exact tirzepatide response, but they can support a more informed conversation with your provider about whether you may benefit from lower-dose initiation, faster titration, or a higher maintenance dose
At ASPN, tirzepatide is positioned as anadvanced metabolic signaling therapy, implemented selectively when dual-pathway incretin support is clinically appropriate and always within a long-term strategy focused on insulin sensitivity, metabolic signaling integrity, and sustainable outcomes